Member access

4-Traders Homepage  >  Shares  >  PINK SHEETS LLC (NQB)  >  EpiCept Corp    EPCT   US2942643048

EPICEPT CORP

 (EPCT)

0
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsForum 
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Logo
Logo EpiCept Corp
Surperformance© rating of EpiCept Corp
Overall rating In sector In country
Trading Rating - - -
Investor Rating - - -
Growth (Revenue) - - -
Valuation - - -
Finances - - -
Profitability
Earnings quality
Business Predictability - - -
PER - - -
Potential - - -
Yield - - -
Consensus - - -
7 days EPS revision - - -
4 months EPS revision - - -
1 year EPS revision - - -
4 months Revenue revision - - -
1 year Revenue revision - - -
More Ratings
Sector Pharmaceuticals - Diversified
CountryTrading RatingInvestor Rating
JOHNSON & JOHNSONUSA
ROCHE HOLDING LTD.Switzerland
PFIZER INC.USA
NOVARTIS AGSwitzerland
SANOFIFrance
MERCK & CO., INC.USA
GLAXOSMITHKLINE PLCUnited Kingdom
BAYER AGGermany
NOVO NORDISK A/SDenmark
BRISTOL MYERS SQUIBB CO.USA
ELI LILLY & CO.USA
ABBOTT LABORATORIESUSA
TEVA PHARMACEUTICAL INDUSTRIES LIMITEDISRAEL
ALEXION PHARMACEUTICALS, INC.USA
SHIRE PLCUnited Kingdom
ACTAVIS INCUSA
DAIICHI SANKYO COMPANY, LIMITEDJapan
CHUGAI PHARMACEUTICAL CO., LTD.Japan
MYLAN INC.USA
UCBBelgium
BIOMARIN PHARMACEUTICAL INC.USA
TASLY PHARMACEUTICAL GROUP CO LTDCHINA
TAISHO PHARMACEUTICAL HOLDINGS CO LTDJapan
HISAMITSU PHARMACEUTICAL CO., INC.Japan
WARNER CHILCOTT PLCUSA
Sector Pharmaceuticals - Diversified
Data source :
© 2013 Thomson Reuters
Ratings :
© 2013 Surperformance
Advertisement
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.